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Abstract: The phenolic composition of aerial parts from Petiveria alliaceae L., Phyllanthus niruri L.
and Senna reticulata Willd., species commonly used in Costa Rica as traditional medicines, was
studied using UPLC-ESI-TQ-MS on enriched-phenolic extracts. Comparatively, higher values of total
phenolic content (TPC), as measured by the Folin-Ciocalteau method, were observed for P. niruri
extracts (328.8 gallic acid equivalents/g) than for S. reticulata (79.30 gallic acid equivalents/g) whereas
P. alliaceae extract showed the lowest value (13.45 gallic acid equivalents/g). A total of 20 phenolic
acids and proanthocyanidins were identified in the extracts, including hydroxybenzoic acids (benzoic,
4-hydroxybenzoic, gallic, prochatechuic, salicylic, syringic and vanillic acids); hydroxycinnamic acids
(caffeic, ferulic, and p-coumaric acids); and flavan-3-ols monomers [(+)-catechin and (−)-epicatechin)].
Regarding proanthocyanidin oligomers, five procyanidin dimers (B1, B2, B3, B4, and B5) and one
trimer (T2) are reported for the first time in P. niruri, as well as two propelargonidin dimers in
S. reticulata. Additionally, P. niruri showed the highest antioxidant DPPH and ORAC values (IC50
of 6.4 µg/mL and 6.5 mmol TE/g respectively), followed by S. reticulata (IC50 of 72.9 µg/mL and
2.68 mmol TE/g respectively) and P. alliaceae extract (IC50 >1000 µg/mL and 1.32 mmol TE/g
respectively). Finally, cytotoxicity and selectivity on gastric AGS and colon SW20 adenocarcinoma
cell lines were evaluated and the best values were also found for P. niruri (SI = 2.8), followed by
S. reticulata (SI = 2.5). Therefore, these results suggest that extracts containing higher proanthocyanidin
content also show higher bioactivities. Significant positive correlation was found between TPC and
ORAC (R2 = 0.996) as well as between phenolic content as measured by UPLC-DAD and ORAC
(R2 = 0.990). These findings show evidence for the first time of the diversity of phenolic acids in
P. alliaceae and S. reticulata, and the presence of proanthocyanidins as minor components in latter
species. Of particular relevance is the occurrence of proanthocyanidin oligomers in phenolic extracts
from P. niruri and their potential bioactivity.
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1. Introduction
Characterization and quantification of secondary metabolites and their bioactivity studies are
essential to increase the knowledge on plants with traditional medicinal uses towards efficient and safe
utilization. Three plant species of special relevance because of their widespread utilization in traditional
medicine in Costa Rica as anti-inflammatories are Petiveria alliaceae, Phyllanthus niruri and Senna
reticulata [1]. Senna reticulata is a shrub belonging to the Fabaceae family, originally from Mesoamerica
and South America (to Brazil), whose leaves and stems are used traditionally for rheumatism and
skin conditions [2]. Phyllanthus niruri is a shrub native to America and tropical areas of India and
China, which belongs to the Phyllanthaceae family, and has diuretic and hepatoprotective properties [3].
Finally, Petiveria alliacea, which belongs to the Phytholacaceae family, is distributed from the South of
the United States to Brazil and its traditional uses include analgesic, anticoagulant and hypoglycemic
properties [4].
Studies have attributed anti-inflammatory and other bioactivities mainly to anthraquinones
present in S. reticulate [2], sulfur containing compounds in P. alliaceae [4], and lignans such as
phyllanthosides in the case of P. niruri. More recent studies have shown the synergic effect of different
families of phenolic compounds in bioactivity studies, for instance showing the important effects of
proanthocyanidins on antioxidant and cytotoxic bioactivities [5,6]. Regarding phenolic compounds,
mainly flavonoids such as kaempferol derivatives have been reported in S. reticulata [2] [7]; quercetin
derivatives in P. alliacea [8] and P. niruri [9]; whereas caffeic acid derivatives and ellagitannins have
also been reported in P. niruri [10]. Flavan-3-ols, including catechin and epicatechin monomers have
been reported in P. niruri [11], whereas no detailed studies on proanthocyanidin oligomers have been
performed in any of these three species.
Proanthocyanidins are condensed flavan-3-ols that constitute an important group of polyphenols
because of their bioactivities, among others, ant-inflammatory, antioxidant and anti-cancer
activities [12]. Despite the increasing number of studies on phenolics, the characterization of
proanthocyanidins remains a complex task because of the need for high-end techniques such as
High-Resolution Mass Spectrometry (HRMS). On the other hand, it has been argued that these
bioactivities could be mediated by redox interaction, since the regulation on redox homeostasis has
been implicated in the control of the transition from cell proliferation to cell differentiation and cell
cycle progression in both plants and animals [13]. However, the mechanisms and factors that could
affect these bioactivities remain to be elucidated [14], suggesting the importance of these studies.
Since proanthocyanidin composition of P. alliaceae, P. niruri and S. reticulata have been scarcely
studied and because of findings demonstrating the synergic contribution of proanthocyanidins
on plants whose bioactivities were attributed solely to other metabolites [5,15], the objective of
this work was to obtain phenolic extracts from these three plant species and to characterize them
UPLC-DAD-ESI-TQ-MS. Evaluation of the antioxidant activity through DPPH and ORAC methods, as
well as the assessment of cytotoxicity in AGS adenocarcinoma gastric cells, SW620 adenocarcinoma
colon cells, and Vero normal cells, was also carried out in the different extracts.
2. Results and Discussion
2.1. Phenolic Yield and Total Phenolic Contents
The extraction process described in the Materials and Methods section, allowed the phenolic
enriched fractions to be obtained, as summarized in Table 1. S. reticulata presented the highest yield
(6.53%) whereas P. alliaceae showed the lowest value (5.03%). The total phenolic contents (TPC)
Plants 2017, 6, 50 3 of 13
shown in Table 1, also resulted in comparatively lower values for P. alliaceae extract (13.45 gallic acid
equivalents/g dry extract) than P. niruri extract (328.80 gallic acid equivalents/g dry extract), which
exhibited the highest values. These results agree with few reports indicating lower TPC values for
an hydroalcoholic extract of P. alliaceae [16], and for an aqueous extract of S. reticulata [17]. However,
higher TPC values, in the range of 263–270 gallic acid equivalents/g, which are slightly lower than our
findings have been reported for ethanolic extracts of P. niruri [10,18]. Table 1 also summarizes the total
proanthocyanidin (PRO) content for the different extracts. P. niruri showed the highest PRO content
(322.23 cyanidin chloride equivalents/g dry extract) whereas no content was found in P. alliaceae. S.
reticulata showed intermediate values for both TP and PRO contents. Thus, phenolic content varied
according to plant species, the highest values for both TPC and PRO clearly corresponding to P. niruri.
Table 1. Extraction yield and total phenolic content.




Contents (PRO) (mg/g) 3,5
P. alliacea 5.03 13.45 a ± 0.46 nd 4
P. niruri 5.58 328.80 b ± 13.41 322.93 a ± 11.12
S. reticulata 6.53 79.30 c ± 4.09 22.35 b ± 1.64
1 g of extract/g of dry material expressed as %. 2 mg of gallic acid equivalent (GAE)/g extract. 3 mg of cyanidin
chloride equivalent (CCE)/g extract. 4 nd = not detected. 5 Different superscript letters in the same column indicate
differences are significant at p < 0.05.
2.2. Phenolic Profile by UPLC-DAD-ESI-TQ-MS Analysis
Table 2 summarizes the results of UPLC-DAD-ESI-TQ-MS analysis performed in the different
extracts, as described in the Materials and Methods section. Also, Figure S1 and Table S1
(Supplementary Materials) show base chromatograms and main MS/MS parameters respectively.
Among the 28 phenolic compounds screened, a total of 20 phenolic compounds were characterized
and quantified, (benzoic, 4-hydroxybenzoic, gallic, protocatechuic, salicylic, syringic and vanillic
acids); hydroxycinnamic acids (caffeic, ferulic, and p-coumaric acids); and flavan-3-ols monomers
[(+)-catechin and (−)-epicatechin)], procyanidin dimers, propelargonidin dimers and procyanidin
trimers). To our knowledge, our findings report for the first time the presence of proanthocyanidin
oligomers (Figure 1) in extracts from P. niruri and S. reticulata.
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Figure 1. General chemical structure of B-type proanthocyanidins: procyanidins (composed by (epi)
catechin units) and propelargonidins (composed by (epi) afzelechin units).
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Table 2. Phenolic composition of P. alliaceae, P. niruri and S. reticulata extracts.
Compounds P. alliaceae P. niruri S. reticulata
Concentration (µg/g Extract)
Hydroxybenzoic acids
Benzoic acid 158.4 ± 7.5 nd nd
Salicylic acid 175.9 ± 2.4 61.2 ± 1.3 16.7 ± 0.1
4-Hydroxybenzoic acid 28.1 ± 0.2 14.3 ± 0.1 80.9 ± 1.2
Protocatechuic acid 6.3 ± 0.2 192.4 ± 0.9 36.3 ± 0.3
Gallic acid 2.4 ± 0.0 763.3 ± 8.1 7.5 ± 0.3
Vanillic acid 12.1 ± 0.1 10.7 ± 0.2 49.6 ± 1.7
Syringic acid 9.2 ± 0.4 nd 25.0 ± 0.8
∑ Hydroxybenzoic acids 392.4 1041.9 216.0
Hydroxycinnamic acids
p-Coumaric acid 31.6 ± 0.4 13.5 ± 0.8 39.0 ± 0.9
Caffeic acid 1.6 ± 0.0 25.0 ± 0.8 52.8 ± 0.6
Ferulic acid 47.5 ± 1.1 34.7 ± 1.1 372.5 ± 9.5
∑ Hydroxycinnamic acids 80.7 73.2 464.3
Flavan-3-ols: monomers
(+)-Catechin nd 186.6 ± 6.4 3.7 ± 0.1
(−)-Epicatechin nd 331.7 ± 8.3 14.0 ± 0.1
∑ Monomers nd 518.3 17.7
Flavan-3-ols: procyanidin dimers
Procyanidin B1 nd 44.2 ± 1.5 nd
Procyanidin B2 nd 73.0 ± 3.2 nd
Procyanidin B3 nd 45.8 ± 1.6 nd
Procyanidin B4 nd 74.0 ± 1.5 nd
Procyanidin B5 nd 13.2 ± 0.3 nd
∑ Procyanidin dimers nd 250.2 nd
Flavan-3-ols: propelargonidin dimers
Propelargonidin dimer (5.03 min) nd nd 4.9 ± 0.1
Propelargonidin dimer (5.63 min) nd nd 5.9 ± 0.2
∑ Properlargonidin dimers nd nd 10.8
Flavan-3-ols: procyanidin trimers
Trimer T2 nd 26.0 ± 0.6 nd
∑ Procyanidin trimers nd 26.0 nd
nd—not detected.
In fact, five different procyanidin dimers, namely B1, B2, B3, B4 and B5 were found in P. niruri
extract, two propelargonidin dimers (with retention times of 5.03 and 5.63 min) were detected in
S. reticulata, whereas procyanidin trimer T was determined in P. niruri. On the other hand, flavan-3-ols
monomers, namely (+)-catechin and (−)-epicatechin, were found in both P. niruri and S. reticulata,
constituting to our knowledge, the first report for both monomers in this latter plant species. In contrast,
proanthocyanidins were not detected in P. alliaceae extract.
However, P. alliacea was the richest extract in phenolic acids, particularly in hydroxybenzoic
acids which constituted 82.9% of total phenolic content whereas hydroxycinnamic acids accounted for
17.1% of such content. S. reticulata exhibited the highest proportion of hydroxycinnamic acids (65.5%),
followed by hydroxybenzoic acids (30.5%) and proanthocyanidin monomers (i.e., (+)-catechin and
(−)-epicatechin) (2.5%). S. reticulata also showed two propelargonidin dimers (1.5%), which constitute
an important group of compounds due to their particular bioactivities [6,19]. Finally, P. niruri presented
the highest content of proanthocyanidins, representing 41.6% of total phenolic content, hydroxybenzoic
acids representing the remaining 54.6% of the total content.
P. niruri also exhibited the highest structural diversity of proanthocyanidins. Besides the
flavan-3-ol monomers (−)-epicatechin and (+)-catechin constituting 17.4% and 9.8%, respectively,
procyanidin dimers accounted for 13.1% and procyanidin trimer T2 [(−)-epicatechin-(4β→8)-
Plants 2017, 6, 50 5 of 13
(−)-epicatechin-(4β→8)-(+)-catechin] for 1.4%. These oligomers are important compounds because of
their bioactivity as anti-inflammatory agents [20].
Procyanidin dimer B4 [(+)-(catechin-(4α→8)-(−)-epicatechin] (3.9%) was the most abundant
in the extract of P. niruri, followed by B2 [(−)-epicatechin-(4α→8)-(−)-epicatechin] (3.8%), B3
[(+)-catechin-(4α→8)-(+)-catechin] (2.4%) and B1 [(−)-epicatechin-(4β→8)-(+)-catechin] (2.3%), while
procyanidin B5 [(−)-epicatechin-(4β→6)-(−)-epicatechin] showed the lowest proportion (0.7%).
Regarding phenolic acids, salicylic acid (37.2%) and benzoic acid (33.5%) were the main
components in P. alliaceae, followed by ferulic acid (10%), p-coumaric acid (6.7%) and 4-hydroxybenzoic
acid (5.9%). In P. niruri extract, gallic acid is the single most abundant phenolic acid (40.0%), followed
by protocatechuic acid (10.1%); whereas in S. reticulata, ferulic acid is the main component (52.6%)
followed by 4-hydroxybenzoic acid (11.4%), caffeic acid (7.4%), vanillic acid (7.0%), p-coumaric acid
(5.5%) and protocatechuic acid (5.1%).
The total UPLC contents were in agreement with the total phenolics (TPC) as measured by the
Folin-Ciocalteau (Tables 1 and 2). For instance, P. niruri showed the higher contents by both methods
(TPC of 328.8 mg GAE/g extract and UPLC value of 1909.9 µg/g extract), followed by S. reticulata
which exhibited intermediate values (TPC of 72.3 mg GAE/g extract and UPLC value of 708.8 µg/g
extract), and finally by P. alliacea (TPC of 13.45 mg GAE/g extract and UPLC value of 473.0 µg/g
extract).
Finally, the total proanthocyanidin (PRO) contents was also in agreement with the UPLC findings.
For instance, P. niruri showed the highest PRO value by both methods (322.93 mg CCE/g extract and
UPLC value of 794.5 µg/g extract), followed by S. reticulata (PRO of 22.35 mg CCE/g extract and UPLC
value of 25.6 µg/g extract), whereas no proanthocyanidin content were obtained by either method for
P. alliaceae.
2.3. Antioxidant Activity
The DPPH and ORAC values are summarized in Table 3. In both antioxidant tests, values varied
in the following order: P. niruri (IC50 (DPPH) 6.4 µg/mL and 6.5 mmol Trolox equivalents/g) > S.
reticulata (IC50 (DPPH) 72.9 µg/mL and 2.68 mmol Trolox equivalents/mg) > P. alliaceae (IC50 (DPPH)
> 1000 µg/mL and 1.32 mmol Trolox eq/mg).
Table 3. Total phenolic contents (UPLC-DAD-ESI-TQ-MS analysis) and antioxidant activity.







P. alliacea 473.0 >1000 a 1.32 a ± 0.11
P. niruri 1909.6 6.40 b ± 0.10 6.50 b ± 0.15
S. reticulata 708.8 72.90 c ± 1.10 2.68 c ± 0.28
1 Σ = [hydroxybenzoic acids + hydroxycinnamic acids + flavan-3-ols monomers + procyanidin dimers +
propelargonidin dimers + procyanidin trimers] contents (µg/g extract) (Table 2). 2 Different superscript letters in
the same column indicate differences are significant at p < 0.05.
Regarding antioxidant values, our results are in agreement with other published results.
For instance, low antioxidant values have also been reported for hydro-alcoholic extracts of P. alliaceae
(DPPH, IC50 255 µg/mL) [21]. For S. reticulata, values varied according to the method (TEAC,
0.03 mmoL TE/g; ORAC, 0.23 mmol TE/g) [17] and were lower when compared to ORAC values
obtained herein. There is no report on DPPH for S. reticulata, but when comparing to other Senna species,
IC50 values range between 89–424 µg/mL for ethanolic extracts of S.gardneri, S. splendida, S.macranthera
and S. trachypus [22], thus a better result is obtained in our case for S. reticulata enriched-extract.
Finally, the higher antioxidant values found for P. niruri are in agreement with reports from
the literature using DPPH method. For instance, studies on aqueous extracts report IC50 values of
15.3 µg/mL [3] and 6.85 µg/mL [18], whereas IC50 values of 9.1 µg/mL and 11.07 µg/mL were
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reported for methanolic [3] and ethanolic [18] extracts respectively. However, other studies reported
lower antioxidant activity for a hydro-alcoholic extract (IC50 = 32.64 µg/mL) [10]. Therefore, our
DPPH results for P. niruri are better than previous studies.
The difference in antioxidant values among P. alliaceae, S. reticulata and P. niruri extracts could
be attributed to the differences in their phenolic content and distribution. Therefore, in order to
investigate if the phenolic composition contributes to the antioxidant activity, a correlation analysis
was carried out between DPPH and ORAC values, and the total phenolic contents (TPC, Table 1), as
well as with the content by UPLC (Table 3). No correlation was found for DPPH, however, a significant
and positive correlation was observed between TPC and ORAC values (R2 = 0.996) and between UPLC
contents and ORAC values (R2 = 0.990). Therefore, our results are in agreement with previous studies
reporting correlation between total polyphenolic contents and ORAC antioxidant activity [17].
2.4. Cytotoxicity of P. alliaceae, P. niruri and S. reticulata Extracts
Table 4 summarizes the IC50 values for the cytotoxicity of P. alliaceae, P. niruri and S. reticulata
extracts on AGS human gastric adenocarcinoma, SW620 human colon adenocarcinoma and Vero
monkey normal epithelial kidney cell lines. Also, Figure 2 shows dose-response curves. IC50 values
indicate that there is no significant difference (one-way analysis of variance (ANOVA) followed by
Tukey’s post hoc test) between cytotoxicity values (p < 0.05) against gastric AGS adenocarcinoma cells
and SW620 adenocarcinoma cells for P. alliacea and S. reticulata extracts. However, in the case of P. niruri
extract, the ANOVA indicates that the cytotoxicity results are dependent on the cancer cell line.
Table 4. Cytotoxicity of extracts to gastric (AGS) and colon (SW620) adenocarcinoma cells as well as to
control Vero cells.
Sample IC50 (µg/mL)
AGS 1 SW620 1 Vero 1
P. alliacea 2 106.5 a,* ± 7.9 (SI = 1.4) 108.4 a,* ± 4.7 (SI = 1.4) 151.5 a,+ ± 3.3
P. niruri 2 145.2 b,* ± 8.2 (SI = 2.2) 113.2 a,+ ± 4.3 (SI = 2.8) 311.9 b,♦ ± 24
S. reticulata 2 208.4 c,* ± 8.9 (SI = 2.4) 202.5 b,* ± 9.1 (SI = 2.5) >500 c,+
1 Different superscript letters in the same column indicate differences are significant at p < 0.05. 2 Different
superscript signs in the same row indicate differences are significant at p < 0.05.
Our results for the cytotoxicity of P. alliacea on both adenocarcinoma cell lines are similar to those
reported for an ethanolic extract on Jurkat T cells [23]. Other studies indicate variability of results, with
IC50 values ranging from 29 to 36 µg/mL for a C-18 chromatographic fraction of a hydro-alcoholic
extract on erythroleukema and melanoma cell lines [24], and breast adenocarcinoma 4T1 cell line [25].
In contrast, no cytotoxic effect was observed for a methanolic extract on hepatic adenocarcinoma
HepG2 [26].
For S. reticulata extracts, the results for the cytotoxicity are in agreement with a study reporting
IC50 of 232.9 µg/mL for a methanolic extract on KB nasopharyngeal cells. However, no cytotoxicity
was found in aqueous extracts [27]. Studies on other species of the genus Senna, including a methanolic
extract of S. covesii, also reported no activity (IC50 > 800 µg/mL) on L929 tumor connective tissue cell
line, HeLa cervix carcinoma and C3F6 lymphoma [28].
Finally, the cytotoxicity results obtained for the P. niruri extract on AGS tumor gastric cell lines
and SW620 tumor colon cell lines, are similar to those found in the literature for methanolic and
aqueous extracts on PC-3 prostate cancer cell lines (IC50 values of 117.7 and 155.0 µg/mL respectively),
MeWo skin cancer cell lines (IC50 values of 153.3 and 193.3 µg/mL respectively) [29], and for an
hydro-methanolic extract on MCF-7 human breast carcinoma cell lines (IC50 of 84.88 µg/mL) [30].
Similar to our cell line-dependence findings for P. niruri phenolic extracts, other studies performed
on hydro-methanolic extracts of P. amarus and P. virgatus report lower cytotoxicity on Hep G2 hepatic
carcinoma (IC50 > 250 µg/mL) [31].
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reticulata extract exhibited a slightly lower value on SW620 colon cancer cells (SI = 2.5) and on AGS 
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Figure 2. Cytotoxicity dose-response curves of extract treatment on tumoral cell lines. (a) Petiveria
alliacea, (b) P. niruri, (c) S. reticulate. Results represent the mean ± SE of triplicates of one representative
experiment of each cell line.
Concerning the selectivity of the cytotoxic activity of extracts against cancerous cell in normal
Vero cells, our results indicate significant difference (ANOVA, p < 0.05) between IC50 values for both
AGS and SW620 adenocarcinoma cell lines and normal Vero cells. When comparing selectivity index
(SI), defined as the ratio of IC50 values of normal (Vero) cells to cancer cells (AGS or SW620), P. alliaceae
extract showed the lowest values on both cell lines (SI = 1.4), while P. niruri extract showed the best
selectivity result for SW620 colon cancer cells (SI = 2.8), which is in agreement with the selectivity
range (SI ≥ 3) reported as promising for further anticancer studies [32,33]. In turn, S. reticulata extract
exhibited a slightly lower value on SW620 colon cancer cells (SI = 2.5) and on AGS gastric cancer cells
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(SI = 2.4), followed by P. niruri extract on SW620 cells (SI = 2.2). This variability has been reported in
previous studies, showing selective cytotoxicity of a polyphenolic extract between gastric normal and
cancer cells [34], whereas other studies report no selectivity on the cytotoxic effect in normal, as well
as in cancer breast and prostate cell lines [35].
In fact, mechanisms related to the effect of polyphenols in cancer cells need to be elucidated,
taking into account, for instance, the multiplicity of targets that can be reached [14] and the complexity
of factors modulating cancer cell phenotypes [36]. However, there is enough evidence to support
the potential anticancer effects of proanthocyanidins [12]. For instance, previous studies using
proanthocyanidins from grape seeds showed a cytotoxic effect in cervix cancer [37], whereas cranberries
polyphenols inhibited proliferation in prostate and colon cancer cells [38]. Also, other studies indicated
the potential of propelargonidin dimers and procyanidin dimers and contents on higher and more
selective cytotoxicity in gastric and colon cancer cell lines [6]. In addition, a report on another main
component of P. niruri extract, gallic acid, indicates that this compound inhibits the growth of human
hepatocellular carcinoma cells and induces apoptosis in these cell lines [39]. Since polyphenols could
work in a synergistic manner, fractioning of S. reticulata and P. niruri extracts would contribute to
further elucidate the structure-bioactivity relationship of these plant extracts.
3. Materials and Methods
3.1. Materials, Reagents and Solvents
Petiveria alliaceae, Phyllanthus niruri and Senna reticulata aerial plant material were acquired from
local communities that grow and use the plants as traditional medicine, grouped as an Agricultural
Producers Association (AMPALEC) in the Caribbean region. All plants were identified with the
support of the Costa Rican National Herbarium and vouchers are deposited there. The material of
each plant was rinsed in water and cut into small pieces. Subsequently, it was dried in a stove at 40◦C
until completely dry, and after being ground, it was preserved at −5 ◦C. Reagents such as AAPH,
fluorescein, DPPH, and Trypsin-EDTA solution were provided by Sigma-Aldrich (St. Louis, MO,
USA), while amphotericin B, penicillin-streptomycin, and Minimum essential Eagle’s medium (MEM,
10% fetal bovine serum), were purchased from Life Technologies (Carlsbad, CA, USA). AGS human
gastric adenocarcinoma, SW 620 human colorectal adenocarcinoma and Vero monkey normal epithelial
kidney cell lines were obtained from American Type Culture Collection (ATCC, Rockville, MD, USA).
DMSO was provided by Sigma-Aldrich (St. Louis, MO, USA), while MTBE, chloroform and methanol
were purchased from Baker (Center Valley, PA, USA).
3.2. Phenolic Extracts from P. alliaceae, P. niruri and S. reticulata
The process followed for obtaining phenolic-enriched extracts was formerly described by our
group [40]. Briefly, dried material from each plant was first extracted in a mixture of methyl ter-butyl
ether (MTBE) and methanol (MeOH) 90:10 (v/v) at 25 ◦C during 30 min in ultrasound. Afterwards
it was extracted for 24 h in order to obtain a non-polar extract of the samples. After filtration, the
extraction was repeated once. The extracts were combined and the solvents evaporated in a rotavapor
to dryness and subsequently washed with MeOH in order to extract any polyphenols. The residual
plant material was extracted with MeOH at 25 ◦C during 30 min in ultrasound, and then extracted for
24 h. After filtration, the extraction was repeated twice. The three methanol extracts were combined
with the previous MeOH washings and were evaporated in a rotavapor to dryness. Finally, the
dried extract was washed with hexane, MTBE and chloroform consecutively in order to obtain a
phenolic rich-extract.
3.3. Total Phenolic Content
The polyphenolic content was determined by a modification of the Folin-Ciocalteu (FC)
method [41], whose reagent is composed of a mixture of phosphotungstic and phosphomolybdic
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acids. Each sample was dissolved in MeOH (0.1% HCl) and combined with 0.5 mL of FC reagent.
Afterwards 10 mL of Na2CO3 (7.5%) were added and the volume was completed to 25 mL with water.
Blanks were prepared in a similar way but using 0.5 mL of MeOH (0.1% HCl) instead of sample. The
mixture was let standing in the dark for 1 h and then absorbance was measured at 750 nm. Values
obtained were extrapolated in a gallic acid calibration curve. Total phenolic content was expressed as
mg gallic acid equivalents (GAE)/g sample. Analyses were performed in triplicate.
3.4. Total Proanthocyanidin Content
The proanthocyanidin content was determined by a modification of the Bate-Smith method, which
consists of the cleavage of the C–C interflavanic bond of proanthocyanidins in butanol-HCl through
oxidative acid-catalysis [42]. Briefly, 0.2 mL of each sample were mixed with 20 mL of butanol/HCl
(50:50) and 0.54 mM FeSO4. The mixture was incubated at 90 ◦C for 1 h and after cooling, the volume
was completed to 25 mL with butanol-HCl mixture. The absorbance was measured at 550 nm against a
blank prepared in a similar way but without heating. The standard used was cyanidin chloride (which
served to draw a calibration curve. Results were expressed as mg of cyanidin chloride equivalents
(CAE)/g of extract.
3.5. UPLC-DAD-ESI-TQ-MS Analysis
The UPLC-MS system used to analyze the phenolic composition of the samples consisted of an
UPLC coupled to an Acquity PDA eλ photodiode array detector (DAD) and an Acquity TQD tandem
quadrupole mass spectrometer equipped with Z-spray electrospray interface (UPLC-DAD-ESI-TQ-MS)
(Waters, Milford, MA, USA). The analyses were performed using a solution of 5 mg/mL of each extract
in acetonitrile:H2O (1:4). A volume of 2 µL was injected and a Waters® BEH C18 column (2.1 × 100
mm; 1.7 µm) was used. The elution consisted of a gradient composed of solvent A-water:acetic acid
(98:2, v/v) and B-acetonitrile:acetic acid (98:2, v/v) [43]: 0–1.5 min: 0.1% B, 1.5–11.17 min: 0.1–16.3% B,
11.17–11.5 min: 16.3–18.4% B, 11.5–14 min: 18.4% B, 14–14.1 min: 18.4–99.9% B, 14.1–15.5 min: 99.9% B,
15.5–15.6 min: 0.1% B, 15.6–18 min: 0.1% B. The flow rate was 0.5 mL/min and DAD was recorded
between 250–420 nm. ESI negative mode parameters included: source temperature, 130 ◦C; capillary
voltage, 3 kV; desolvation temperature, 400 ◦C; cone gas (N2) flow rate, 60 L/h; and desolvation gas
(N2) flow rate, 750 L/h. For quantification, MRM transitions were used, such as m/z 169/125 for gallic
acid, m/z 289/245 for (+)-catechin and (−)-epicatechin, m/z 577/289 for procyanidin dimers, m/z
561/289 for propelargonidin dimers, and m/z 865/577 for procyanidin trimers. Commercial standards
used were (−)-epicatechin, (+)-catechin, procyanidins B1 and B2. Assignment of procyanidins B3, B4
and B5 and procyanidin trimer T2 was performed with previously isolated standards and confirmed
by MS/MS spectrum. Assignment of propelargonidins was performed through MS/MS spectrum at
m/z 561 and quantification was performed on the calibration curve of procyanidin B1. The limit of
detection (LOD) and limit of quantification (LOQ) are published elsewhere [43,44].
3.6. DPPH Radical-Scavenging Activity
A solution of 2,2-diphenyl-1-picrylhidrazyl (DPPH) (0.25 mM) was prepared using methanol as
solvent. Next, 0.5 mL of this solution were mixed with 1 mL of extract at different concentrations, and
incubated at 25◦ C in the dark for 30 min. DPPH absorbance was measured at 517 nm. Blanks were
prepared for each concentration. The percentage of the radical-scavenging activity of the sample was
plotted against its concentration to calculate IC50, which is the amount of sample required to reach the
50% radical-scavenging activity. The samples were analyzed in triplicate.
3.7. ORAC Antioxidant Activity
Extracts (0.05 g) were mixed with 10 mL of methanol/HCl (1000:1, v/v) and sonicated for
5 min. Afterwards, the mixture was centrifuged and filtered. Fluorescein was used as fluorescence
probe [45]. The reaction was performed in 75 mM phosphate buffer (pH 7.4) at 37 ◦C. The final assay
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mixture consisted of AAPH (12 mM), fluorescein (70 nM), and either Trolox (1–8 µM) or the extract
at different concentrations. Fluorescence was recorded every minute for 98 min in black 96-well
untreated microplates (Nunc, Denmark), using a Polarstar Galaxy plate reader (BMG Labtechnologies
GmbH, Offenburg, Germany) with 485-P excitation and 520-P emission filters. Fluostar Galaxy
software version 4.11-0 (BMG Labtechnologies GmbH, Offenburg, Germany) was used to measure
fluorescence. Fluorescein was diluted from a stock solution (1.17 mM) in 75 mM phosphate buffer (pH
7.4), while AAPH and Trolox solutions were freshly prepared. All reaction mixtures were prepared in
duplicate and three independent runs were completed for each extract. Fluorescence values obtained
were normalized to the curve of the blank (no antioxidant). The area under the fluorescence decay
curve (AUC) was calculated from the normalized curves, and the net AUC was then established.
Subsequently, regression equation between antioxidant concentration and net AUC was obtained.
Finally, ORAC value was estimated by dividing the slope of the latter equation by the slope of the
Trolox line. ORAC values were expressed as mmol of Trolox equivalents (TE)/g of extract.
3.8. Evaluation of Cytotoxicity
The AGS, SW620 and Vero cells were grown in MEM (10% FBS) in the presence of glutamine
(2 mmol/L), penicillin (100 IU/mL), streptomycin (100 µg/L) and amphotericin B (0.25 µg/m), at
37 ◦C, in a humidified atmosphere (5% CO2) [5]. Briefly, 100 µL of 1.5 × 105 cells/mL (suspension)
were seeded overnight into 96-well plates to reach 100% confluency. Subsequently, the cells were
exposed for 48 h to 50 µL of extracts in concentrations varying 15–500 µg/mL in MEM (DMSO 0.1%
v/v). Afterwards, the medium was eliminated, cells were washed with PBS (100 µL) and incubated
with 100 µL of a MTT solution (0.5 mg/mL, final concentration) in PBS, for 2 h at 37 ◦C. Then, MTT
was removed and the formazan crystals were dissolved in 100 µL of ethanol 95%. Absorbance was
read at 570 nm in a microplate reader. DMSO was diluted in media in the same way as the extracts
and incubated with the cells for 48 h to be used as control. Dose-response curves were established and
IC50 was calculated. Extracts were tested in three independent experiments with different doses of
extract analyzed in triplicate.
4. Conclusions
This study represents the first detailed MS analysis of phenolic-enriched extracts of P. alliaceae,
P. niruri and S. reticulata, three species commonly used in traditional medicine in Costa Rica.
Using different methods, including UPLC-DAD-ESI-TQ-MS techniques, results show diverse contents
and distribution of 20 phenolic acids and proanthocyanidins among extracts. These findings constitute
the first report on the diversity of phenolic acids in P. alliaceae and S. reticulata, and the presence of
proanthocyanidins as minor components in this latter extract. In addition, five procyanidin dimers and
one procyanidin trimer, were also detected for the first time in P. niruri. Further, significant positive
correlation was found between total phenolic contents (TPC) and ORAC (R2 = 0.996) antioxidant
value as well as between UPLC contents and ORAC (R2 = 0.990). P. niruri extract showed the highest
antioxidant values in both DPPH and ORAC methods, as well as better cytotoxicity and selectivity on
AGS gastric adenocarcinoma and SW620 colon adenocarcinoma cell lines in respect to normal cells.
These results suggest that the high content of proanthocyanidins (41.6% of total phenolic content) found
in P. niruri extracts could be responsible for the higher cytotoxicity and selectivity of the plant compared
to the other two species from this study. Finally, the results show evidence of the potential health
effects of P. niruri extracts on gut-related diseases, considering these polyphenols are metabolized by
the gut [15,43]. Purification or fractioning of P. niruri phenolic extracts would be of interest to further
evaluate their structure-bioactivity relationship.
Supplementary Materials: The following are available online at http://www.mdpi.com/2223-7747/6/4/50/s1,
Figure S1: Chromatograms (UPLC-DAD) for polyphenolic compounds: (a) P. alliaceae extract, (b) P. niruri extract,
(c) S. reticulata extract, Table S1: UPLC and MS/MS parameters for the identified polyphenols.
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